Compare BIO & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | MKSI |
|---|---|---|
| Founded | 1952 | 1961 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 16.4B |
| IPO Year | N/A | 1997 |
| Metric | BIO | MKSI |
|---|---|---|
| Price | $265.66 | $236.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $358.50 | $256.00 |
| AVG Volume (30 Days) | 237.8K | ★ 1.2M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | N/A | ★ 55.52 |
| EPS | N/A | ★ 4.37 |
| Revenue | N/A | ★ $3,931,000,000.00 |
| Revenue This Year | $2.74 | $15.64 |
| Revenue Next Year | $3.05 | $10.58 |
| P/E Ratio | ★ $9.72 | $53.47 |
| Revenue Growth | N/A | ★ 9.62 |
| 52 Week Low | $211.43 | $54.84 |
| 52 Week High | $343.12 | $269.91 |
| Indicator | BIO | MKSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 54.40 |
| Support Level | $239.33 | $209.20 |
| Resistance Level | $289.61 | $246.35 |
| Average True Range (ATR) | 7.68 | 11.25 |
| MACD | 0.48 | -0.44 |
| Stochastic Oscillator | 24.82 | 76.96 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.